Endosonics has received Food and Drug Administration approvalfor its latest version of the Oracle Micro line of ultrasoundimaging catheters. The Pleasanton, CA, firm announced last monththat the FDA had given the go-ahead to Oracle Micro Plus,
Endosonics has received Food and Drug Administration approvalfor its latest version of the Oracle Micro line of ultrasoundimaging catheters. The Pleasanton, CA, firm announced last monththat the FDA had given the go-ahead to Oracle Micro Plus, whichcombines on a single catheter a solid-state imaging transducerand a percutaneous transluminal coronary angioplasty (PTCA) balloon.Endosonics said Oracle Micro Plus confers significant advantagesover its previous version of the product, which the FDA approvedlast year (SCAN 10/26/94). Oracle Micro Plus is especially wellsuited for coronary stenting procedures, the company said.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.